tradingkey.logo

Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth

ReutersMar 5, 2026 12:56 AM


Overview

  • Canada pharmacy service provider's Q4 revenue slightly beat analyst expectations

  • Adjusted EBITDA for Q4 also beat expectations

  • Company commenced paying dividends and repurchased shares in 2025


Outlook

  • CareRx declares Q1 2026 dividend of C$0.02 per share payable April 9, 2026

  • Company aims to capture growth through home operator expansion plans

  • CareRx focuses on efficient scaling to drive future growth


Result Drivers

  • BED GROWTH - Increase in average beds serviced to 92,250 in Q4 2025 from 87,658 in Q4 2024 contributed to revenue growth

  • COST SAVINGS - Adjusted EBITDA margin improved due to cost savings initiatives

  • PLATFORM EXPANSION - Expanded platform with over 4,500 additional beds supports growth potential


Company press release: ID:nNFCD05mb


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Slight Beat*

C$96.08 mln

C$95.27 mln (3 Analysts)

Q4 Net Income

C$23.79 mln

Q4 Adjusted EBITDA

Beat

C$8.81 mln

C$8.47 mln (3 Analysts)

Q4 Adjusted EBITDA Margin

9.20%

Q4 EBITDA

C$7.10 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI